部分论文：
Wang, X.; Cheng, R.; Zhong, Z., Facile Fabrication of Robust, Hyaluronic Acid-Surfaced and Disulfide-Crosslinked PLGA Nanoparticles for Tumor-Targeted and Reduction-Triggered Release of Docetaxel. Acta Biomater. 2021. DOI:10.1016/j.actbio.2021.02.044
Wang, H.; Wang, X.; Zhang, Y.; Cheng, R.; Yuan, J.; Zhong, Z., Systemic Delivery of NAC-1 siRNA by Neuropilin-Targeted Polymersomes Sensitizes Antiangiogenic Therapy of Metastatic Triple-Negative Breast Cancer. Biomacromolecules 2020, 21, 5119-5127.
Wang, X.; Cheng, R.; Cheng, L.; Zhong, Z., Lipoyl Ester Terminated Star PLGA as a Simple and Smart Material for Controlled Drug Delivery Application. Biomacromolecules 2018, 19, 1368-1373.
Gu, Z.; Wang, X.; Cheng, R.; Cheng, L.; Zhong, Z., Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma. Acta Biomater. 2018, 80, 288-295.
Zhong, P.; Meng, H.; Qiu, J.; Zhang, J.; Sun, H.; Cheng, R.; Zhong, Z., alpha(v)beta(3) Integrin-targeted reduction-sensitive micellarmertansine prodrug: Superb drug loading, enhanced stability, and effective inhibition of melanoma growth in vivo. J. Controlled Release 2017, 259, 176-186.
Zhong, P.; Gu, X.; Cheng, R.; Deng, C.; Meng, F.; Zhong, Z., alpha(v)beta(3) integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo. Int. J. Nanomed. 2017, 12, 7913-7921.
Wu, K.; Cheng, R.; Zhang, J.; Meng, F.; Deng, C.; Zhong, Z., Micellar nanoformulation of lipophilized bortezomib: high drug loading, improved tolerability and targeted treatment of triple negative breast cancer. J. Mater. Chem.B 2017, 5, 5658-5667.
Zhong, P.; Zhang, J.; Deng, C.; Cheng, R.; Meng, F.; Zhong, Z., Glutathione-Sensitive Hyaluronic Acid-SS-Mertansine Prodrug with a High Drug Content: Facile Synthesis and Targeted Breast Tumor Therapy. Biomacromolecules 2016, 17, 3602-3608.
Wang, X.; Zhang, J.; Cheng, R.; Meng, F.; Deng, C.; Zhong, Z., Facile Synthesis of Reductively Degradable Biopolymers Using Cystamine Diisocyanate as a Coupling Agent. Biomacromolecules 2016, 17, 882-890.
Zhong, Y.; Zhang, J.; Cheng, R.; Deng, C.; Meng, F.; Xie, F.; Zhong, Z., Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+human breast tumor xenografts. J. Controlled Release 2015, 205, 144-154.
Lu, W.; Wang, X.; Cheng, R.; Deng, C.; Meng, F.; Zhong, Z., Biocompatible and bioreducible micelles fabricated from novel alpha-amino acid-based poly(disulfide urethane)s: design, synthesis and triggered doxorubicin release. Polym. Chem. 2015, 6, 6001-6010.
Huang, F.; Cheng, R.; Meng, F.; Deng, C.; Zhong, Z., Micelles Based on Acid Degradable Poly(acetal urethane): Preparation, pH-Sensitivity, and Triggered Intracellular Drug Release. Biomacromolecules 2015, 16, 2228-2236.
Cheng, R.; Meng, F.; Deng, C.; Zhong, Z., Bioresponsive polymeric nanotherapeutics for targeted cancer chemotherapy. Nano Today 2015, 10, 656-670.
Cheng, R.; Meng, F.; Deng, C.; Klok, H.-A.; Zhong, Z., Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 2013, 34, 3647-3657.
Cheng, R.; Wang, X.; Chen, W.; Meng, F.; Deng, C.; Liu, H.; Zhong, Z., Biodegradable poly(epsilon-caprolactone)-g-poly(2-hydroxyethyl methacrylate) graft copolymer micelles as superior nano-carriers for smart doxorubicin release. J. Mater. Chem. 2012, 22, 11730-11738.
Cheng, R.; Meng, F.; Ma, S.; Xu, H.; Liu, H.; Jing, X.; Zhong, Z., Reduction and temperature dual-responsive crosslinked polymersomes for targeted intracellular protein delivery. J. Mater. Chem. 2011, 21, 19013-19020.
Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z., Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J. Controlled Release 2011, 152, 2-12.